# Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach

> **NCT07152184** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 288 (estimated)

## Conditions studied

- Patient With Schizophrenia Spectrum Disorder
- NLM Classification WM 203, Psychology:Schizophrenic Psychology
- Schizophrenia Spectrum and Other Psychotic Disorders

## Interventions

- **DRUG:** Use of antipsychotic treatment with marketing authorization at doses lower than those recommended: - Olanzapine - Zuclopenthixol - Risperidone - Pipotiazine palmitate / Pipotiazine - Quetiapine - Flup

## Key facts

- **NCT ID:** NCT07152184
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2032-02-01
- **Final completion:** 2032-02-01
- **Target enrollment:** 288 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07152184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07152184, "Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07152184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*